The importance of this pathway is strongly supported by the evidence that components of this pathway IRF4, Nedd4 and Notch are themselves frequently targeted during CLL development and progression [2, 5, 13, 31]. This evidence concerns the gene IRF4 and B-cell chronic lymphocytic leukemia.